<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03925883</url>
  </required_header>
  <id_info>
    <org_study_id>1R01CA218923-01A1</org_study_id>
    <secondary_id>R01CA218923</secondary_id>
    <nct_id>NCT03925883</nct_id>
  </id_info>
  <brief_title>Predicting and Addressing Colonoscopy in Safety Net Settings</brief_title>
  <acronym>PRECISE</acronym>
  <official_title>Predicting and Addressing Colonoscopy in Safety Net Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sea Mar Community Health Centers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prospective cohort study will evaluate the effectiveness of patient navigation in&#xD;
      community health center settings. The investigators will collaborate with the advisory board,&#xD;
      composed of key clinicians and patients, researchers, and policymakers, to establish a&#xD;
      procedure to conduct and evaluate a patient navigation program that aims to increase rates of&#xD;
      follow-up colonoscopy among diverse patient populations served by safety net clinics. Phase 1&#xD;
      will be a milestone-driven planning process in which the investigators will validate the risk&#xD;
      prediction model and apply the risk prediction model to stratify the patients and adapt&#xD;
      patient navigation materials for the local context. Phase II will be a large-scale, patient&#xD;
      randomized-controlled trial that will include 1200 patients at a large 34-clinic community&#xD;
      health center in Washington State.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will fulfill the following aims:&#xD;
&#xD;
      Aim 1: Validate externally the predictive risk score using Sea Mar CHC's robust data&#xD;
      including 29,000 patients age-eligible for colorectal cancer screening; stratify patients&#xD;
      according to risk of non-adherence to follow-up colonoscopy; and adapt patient navigation&#xD;
      program for the local context.&#xD;
&#xD;
      Aim 2: Assess the effectiveness, costs, and cost-effectiveness of a centralized, phone-based&#xD;
      patient navigation program for follow-up colonoscopy receipt for patients at moderate risk or&#xD;
      high risk for non-adherence.&#xD;
&#xD;
      Aim 3: Assess differences in the intervention arms in secondary outcomes (e.g. time to&#xD;
      colonoscopy receipt, no-show/canceled appointments, colonoscopy quality) and moderators of&#xD;
      intervention effectiveness (e.g. probability level, intervention dose, and patient age,&#xD;
      ethnicity, and sex)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 29, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of follow-up colonoscopy</measure>
    <time_frame>12 months</time_frame>
    <description>Receipt of colonoscopy within 1 year of abnormal Fecal Immunochemical Test (FIT) result</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">732</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Patient Navigation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to this arm will receive patient navigation with the goal of completing a follow-up colonoscopy within 12 months of a positive FIT result.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive usual care screening opportunities</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient navigation</intervention_name>
    <description>Receive up to 6 live phone calls with a patient navigator for education, barrier assessment, and barrier resolution to follow up colonoscopy</description>
    <arm_group_label>Patient Navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Positive FIT test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior colorectal cancer&#xD;
&#xD;
          -  Dialysis patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gloria Coronado, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente Center for Health Research</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 11, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2019</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer screening</keyword>
  <keyword>Cancer screening</keyword>
  <keyword>Risk prediction model</keyword>
  <keyword>Patient navigation</keyword>
  <keyword>Colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

